Atopic Dermatitis — A Phase 1 Study of LT-002-158 Intended for the Treatment of Skind Disorder in Healthy Adult Volunteers
Citation(s)
A Phase 1,Randomized, Placebo-controlled, Single and Multiple Ascending Dose Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Orally Administered LT-002-158 Intended for the Treatment of Skind Disorder in Healthy Adult Volunteers